Artificial Intelligence’s Role in Improving Healthcare

December 17, 2018

The artificial intelligence (AI) healthcare market is expected reach $6.6 billion by 2021, representing a compound annual growth rate (CAGR) of 40 percent over the next five years, according to a report from Accenture. AI in health represents a collection of multiple technologies enabling machines to sense, comprehend, act and learn so they can perform administrative and clinical healthcare functions. Unlike legacy technologies that are only algorithms/ tools that complement a human, health AI today can truly augment human activity.

Spotlight

Medicines Australia

Medicines Australia represents the discovery-driven pharmaceutical industry in Australia. Our member companies supply 86 per cent of the medicines that are available to Australian patients through the Pharmaceutical Benefits Scheme as well as providing a range of other medicines and vaccines to the Australian community. Those medicines keep Australians out of hospitals, prevent disease and play a pivotal role in ensuring a productive and healthy community.

Other Infographics
news image

Pharmaceutical Industry World Economy Scenario

Infographic | May 20, 2022

This product titled One Page Pharmaceutical Industry World Economy Scenario Report Infographic PPT PDF Document is a completely editable document in A4 size designed in Powerpoint.

Read More
news image

Pharma Technology Focus

Infographic | June 3, 2022

Pharma Technology Focus is free to read on all devices.

Read More
news image

Smart Pharmacovigilance

Infographic | May 23, 2021

Pharmacovigilance (PV) is essential to all life science organizations, ensuring that patients' health comes first. Various trends in global healthcare have transformed today’s PV function into a corporate asset that enhances brand value and contributes to new growth opportunities. However, existing safety systems impose a significant cost burden to operate.

Read More
news image

2021 global life sciences outlook

Infographic | August 24, 2021

The life sciences sector has played a pivotal role amid the COVID-19 pandemic. To cope with the global crisis, traditional competitors partnered to accelerate research and develop the fastest novel vaccine in the history. Governments, health systems, payers, retail pharmacies, and nonprofits are now working collaboratively with the sector to provide widespread distribution and administration.

Read More
news image

COVID-19 Summary as of March 13, 2020

Infographic | April 6, 2020

Biomedtracker and Trialtrove have a total of 307 clinical trials for the treatment of COVID-19. 152 initiated trials for the treatment of COVID-19. 155 Trials have been announced but have not yet begun recruitment.

Read More
news image

Latest Improvement on Pharmanews to Serve You Better

Infographic | April 16, 2020

Poised to give our readers and advertisers better services in spite of the COVID19 pandemic, Pharmanews–your global health journal has continued to improve on its services in terms of healthcare information dissemination, by keeping readers abreast of latest development in public health, especially on how to stay safe from the novel Coronavirus, as well as expanding our reach to over 250,000 readers per month.

Read More

Spotlight

Medicines Australia

Medicines Australia represents the discovery-driven pharmaceutical industry in Australia. Our member companies supply 86 per cent of the medicines that are available to Australian patients through the Pharmaceutical Benefits Scheme as well as providing a range of other medicines and vaccines to the Australian community. Those medicines keep Australians out of hospitals, prevent disease and play a pivotal role in ensuring a productive and healthy community.

Events